" class="no-js "lang="en-US"> John B. Whelan - Medtech Alert
Friday, September 26, 2025
John B. Whelan

John B. Whelan

About John B. Whelan

Public and private company pharmaceutical/biotech executive with twenty years of experience managing life science companies.

Successful start-up and turnaround leadership. Work with boards and management to define the company’s vision, create strategic plans, assemble management teams, motivate employees and execute to reach key milestones.

Record of creating enterprise value and attracting investors. Increased valuation 40-fold in a turnaround situation. Raised over $240M through public and private equity financings, collaborations and sale of assets. Extensive M&A experience on both buy and sell sides.

Hands-on general management skills leading teams in all areas including R&D, Manufacturing/QC/QA, Clinical Operations, FDA Regulatory, Finance, IR/PR, Business Development, Commercial Planning, Legal and Administration.

Expertise in biological and small molecule therapeutics, drug delivery systems, discovery platforms, oncology, supportive care and orphan indications.

Related Story

Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19

October 7 2021

Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled “muco-trapping” antibody platform for treating […]